Apellis Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on the development of novel therap...
Bridge Biotherapeutics Inc, a clinical stage biotech company headquartered in Seongnam, South Korea has announced that t...
Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on...
Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...
Singapore - Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...
Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, amon...
Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...
Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...
Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...
Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction o...
Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate dru...
PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and ...
argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...
Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sc...
Singapore –Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy ...
First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...
Singapore – A new multicenter, retrospective analysis of South Korean patients highlighted that the oral targeted ...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...
Vyera Pharmaceuticals, LLC has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...
Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...
Singapore - Philip Morris International (PMI), has conducted an in vitro study using epithelial cells taken from the mou...
Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, Calif...
Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...
Eisai Co., Ltd. and Biogen Inc. announced that Eisai presented the latest data from the Phase II clinical study (Study 2...
Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...
